A systematic review of treatment for patients with burning mouth syndrome.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 128, doi. 10.1177/03331024211036152
- By:
- Publication type:
- Article
Works matching IS 03331024 AND DT 2022 AND VI 42 AND IP 2
Results: 8
1
2
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 176, doi. 10.1177/03331024211036665
- By:
- Publication type:
- Article
3
Micturition-triggered severe headache associated with bladder paraganglioma: A case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
4
Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 119, doi. 10.1177/03331024211046613
- By:
- Publication type:
- Article
5
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 108, doi. 10.1177/03331024211053571
- By:
- Publication type:
- Article
6
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
Are PROMs passing the message? A reflection with real-life migraine patients.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 162, doi. 10.1177/03331024211034509
- By:
- Publication type:
- Article
8
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.
- Published in:
- Cephalalgia, 2022, v. 42, n. 2, p. 170, doi. 10.1177/03331024211034508
- By:
- Publication type:
- Article